Clinical relevance of kras mutation detection in metastatic colorectal cancer treated by cetuximala plus chemotherapy

被引：0
|
作者：
Di fiore, Frederic
Le pessot, Florence
Blanchard, France
Charbonnier, Francoise
Lamy, Aude
Frebourg, Thierry
Michel, Pierre
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A433 / A433
页数：1
相关论文
共 50 条
  • [1] Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
    Di Fiore, F.
    Blanchard, F.
    Charbonnier, F.
    Le Pessot, F.
    Lamy, A.
    Galais, M. P.
    Bastit, L.
    Killian, A.
    Sesboue, R.
    Tuech, J. J.
    Queuniet, A. M.
    Paillot, B.
    Sabourin, J. C.
    Michot, F.
    Michel, P.
    Frebourg, T.
    BRITISH JOURNAL OF CANCER, 2007, 96 (08) : 1166 - 1169
  • [2] Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy
    F Di Fiore
    F Blanchard
    F Charbonnier
    F Le Pessot
    A Lamy
    M P Galais
    L Bastit
    A Killian
    R Sesboüé
    J J Tuech
    A M Queuniet
    B Paillot
    J C Sabourin
    F Michot
    P Michel
    T Frebourg
    British Journal of Cancer, 2007, 96 : 1166 - 1169
  • [3] Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice
    Rossi, Luigi
    Veltri, Enzo
    Zullo, Angelo
    Zoratto, Federica
    Colonna, Maria
    Di Seri, Marisa
    Longo, Flavia
    Mottolese, Marcella
    Giannarelli, Diana
    Ruco, Luigi
    Romiti, Adriana
    Barucca, Viola
    Adua, Daniela
    Tomao, Silverio
    FUTURE ONCOLOGY, 2012, 8 (09) : 1193 - 1197
  • [4] Comparison of methodologies for KRAS mutation detection in metastatic colorectal cancer
    Pinto, Pedro
    Rocha, Patricia
    Veiga, Isabel
    Guedes, Joana
    Pinheiro, Manuela
    Peixoto, Ana
    Pinto, Carla
    Fragoso, Maria
    Sanches, Evaristo
    Araujo, Antonio
    Alves, Fernando
    Coutinho, Camila
    Lopes, Paula
    Henrique, Rui
    Teixeira, Manuel R.
    CANCER GENETICS, 2011, 204 (08) : 439 - 446
  • [5] Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab
    Sastre, Javier
    Vidaurreta, Marta
    Gomez, Auxiliadora
    Rivera, Fernando
    Massuti, Bartomeu
    Reboredo Lopez, Margarita
    Abad, Albert
    Gallen, Manuel
    Benavides, Manuel
    Aranda, Enrique
    Diaz Rubio, Eduardo
    CLINICAL COLORECTAL CANCER, 2013, 12 (04) : 280 - 286
  • [6] KRAS mutation testing in metastatic colorectal cancer
    Cong Tan
    World Journal of Gastroenterology, 2012, (37) : 5171 - 5180
  • [7] KRAS mutation testing in metastatic colorectal cancer
    Tan, Cong
    Du, Xiang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (37) : 5171 - 5180
  • [8] Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer
    Zocche, David M.
    Ramirez, Carolina
    Fontao, Fernando M.
    Costa, Lucas D.
    Redal, Maria A.
    FRONTIERS IN GENETICS, 2015, 6
  • [9] The role of the KRAS G13D mutation in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy plus cetuximab
    Tejpar, S.
    Bokemeyer, C.
    Celik, I.
    Schlichting, M.
    Van Cutsem, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [10] Detection of KRAS Oncogene in Peripheral Blood as a Predictor of the Response to Cetuximab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
    Yen, Li-Chen
    Yeh, Yung-Sung
    Chen, Chao-Wen
    Wang, Hwei-Ming
    Tsai, Hsiang-Lin
    Lu, Chien-Yu
    Chang, Yu-Tang
    Chu, Koung-Shing
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    CLINICAL CANCER RESEARCH, 2009, 15 (13) : 4508 - 4513
12345